Assembly Biosciences (ASMB) Revenue (2017 - 2026)

Assembly Biosciences' Revenue history runs 9 years deep, the most recent figure standing at $8.2 million for Q1 2026.

• In Q1 2026, Revenue fell 12.8% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $71.1 million (up 121.11% YoY), while the FY2025 annual figure was $72.3 million, up 153.52% from the prior year.
• Revenue for Q1 2026 stood at $8.2 million, down from $42.5 million in the prior quarter.
• The five-year high for Revenue was $42.5 million in Q4 2025, with the low at $5.8 million in Q1 2024.
• The 4-year median for Revenue is $8.4 million (2024), against an average of $11.6 million.
• The sharpest annual moves came in 2025 and 2026: Revenue jumped 477.26% in 2025, then dropped 12.8% in 2026.
• Assembly Biosciences' Revenue stood at $7.2 million in 2023, then gained by 2.71% to $7.4 million in 2024, then surged by 477.26% to $42.5 million in 2025, then slumped by 80.66% to $8.2 million in 2026.
• Business Quant data shows ASMB's Revenue at $8.2 million in Q1 2026, $42.5 million in Q4 2025, and $10.8 million in Q3 2025.